Barinthus Biotherapeutics plc American Depositary Shares
Symbol: BRNS (NASDAQ)
1.08
▼ (-2.18%) -0.024
Company Description:
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Key Stats
- Today's Open: $1.079
- Today's High: $1.079
- Today's Low: $1.076
- Today's Volume: 0
- Yesterday Close: $1.1
- Yesterday High: $1.1551
- Yesterday Low: $1.08
- Yesterday Volume: 135.10K
- Last Min Volume: 0
- Last Min High: $1.079
- Last Min Low: $1.076
- Last Min VWAP: $0
Company Profile
- Name: Barinthus Biotherapeutics plc American Depositary Shares
- Website: https://www.barinthusbio.com
- Listed Date: 2021-04-30
- Location: GERMANTOWN, MD
- Market Status: Active
- CIK Number: 0001828185
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $44.79M
- Round Lot: 100
- Outstanding Shares: 40.72M
- Asset Type: ADRC
RECENT FILINGS FOR BRNS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-08 | 8-K/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-10 | 8-K | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-07 | 8-K | View |
| 2025-04-25 | ARS | View |
| 2025-04-25 | DEFA14A | View |
| 2025-04-25 | DEF 14A | View |
| 2025-03-20 | S-8 | View |
| 2025-03-20 | 10-K | View |
| 2025-03-20 | 8-K | View |
| 2025-02-11 | SCHEDULE 13G/A | View |
| 2025-02-05 | 4 | View |
Latest News on BRNS